- Antineuronal antibodies in sporadic late-onset cerebellar ataxia. Bürk K, Wick M, Roth G, Decker P, Voltz, R. J Neurol, 2010, 257:59-62.
- Interleukin-6: from identification of the cytokine to development of targeted treatments. Assier E, Boissier MC, Dayer JM. Joint Bone Spine. 2010 ;77:532-6.
- Blood vessels, a potential therapeutic target in rheumatoid arthritis? Semerano L, Clavel G, Assier E, Denys A, Boissier MC. Joint Bone Spine. 2011;78:118-23.
- Intra-articular electrotransfer of mouse soluble tumour necrosis factor receptor in a murine model of rheumatoid arthritis. Denys A, Thiolat A, Descamps D, Lemeiter D, Benihoud K, Bessis N, Boissier MC J Gene Med. 2010;12:659-68.
- Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment. Miellot-Gafsou A, Biton J, Bourgeois E, Herbelin A, Boissier MC, Bessis N. Immunology. 2010 ;130:296-306.
Li2P INSERM UMR 1125
Physiopathologie, cibles et thérapies de la polyarthrite rhumatoïde
 |
 |
 |
 |
 |
2010
Publications du Li2P INSERM UMR 1125
USPN Campus de Bobigny
